Search Login Register

2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline (NBQX) Summary

Description: structure given in first source; neuroprotectant for cerebral ischemia; AMPA receptor antagonist

Also Known As: NBQX; 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline; 6-nitro-7-sulfamoylbenzo(f)quinoxaline-2,3-dione; FG 9202; FG-9202

Networked: 235 relevant articles (23 outcomes, 13 trials/studies) for this Bio-Agent

Key Diseases for which 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline is Relevant

  1. Seizures (Seizure) : 8 outcomes 2 studies in 67 results
  2. Ischemia : 4 outcomes 4 studies in 38 results
  3. Hyperalgesia : 2 outcomes 3 studies in 14 results
  4. Stroke (Strokes) : 2 outcomes in 4 results
  5. Spinal Cord Injuries (Spinal Cord Injury) : 1 outcome 2 studies in 13 results
Show All >>

Drugs Related to 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline

  1. alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)
  2. 2,3- dioxo- 6- nitro- 7- sulfamoylbenzo(f)quinoxaline (NBQX)
  3. GYKI 52466
  4. AMPA Receptors (AMPA Receptor)
  5. N-Methylaspartate (NMDA)
  6. Kainic Acid (Kainate)
  7. Excitatory Amino Acid Antagonists
  8. Kainic Acid Receptors (Kainate Receptor)
  9. Dizocilpine Maleate (Dizocilpine)
  10. propionic acid (potassium propionate)
Show All >>

Therapies Related to 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline

  1. Intra-Articular Injections
  2. Injections
  3. Resuscitation
  4. Intravitreal Injections
  5. Transplants (Transplant)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.